At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02576 TAIMEI TECH
Closed 01-19 16:08:03
4.250
+0.000
0.00%
High4.480
Low4.190
Vol23.20K
Open4.480
D1 Closing4.250
Amplitude6.82%
Mkt Cap2.40B
Tradable Cap854.25M
Total Shares564.00M
T/O98.51K
T/O Rate0.01%
Tradable Shares201.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
TAIMEI TECH (02576) to Invest RMB70 Million in Establishing Partnership
Zhejiang Taimei Medical Technology Co. Ltd. Announces CSRC Filing for Full Circulation of H Shares, Initiating Regulatory Review for Share Conversion and Hong Kong Listing
Zhejiang Taimei Medical Technology Co Ltd is a China-based company mainly engaged in the provision of digital solutions for the research and development and commercialisation of pharmaceutical and medical device. The Company mainly designs and provides industry-specific software and digital services to a variety of stakeholders in the pharmaceutical and medical device industry. The Company's cloud-based software mainly provides software as a service (SaaS) products and customized products as well as related technical support, including TrialOS, a digital collaboration platform for the research and development of pharmaceutical and medical device, and PharmaOS, a digital collaboration platform for pharmaceutical and medical device commercialization. The Company's digital services mainly include digital clinical research services and independent reading center (IRC) services. The Company principally conducts its businesses in domestic and overseas markets.